JP2006505555A - 骨関節症の治療 - Google Patents

骨関節症の治療 Download PDF

Info

Publication number
JP2006505555A
JP2006505555A JP2004543826A JP2004543826A JP2006505555A JP 2006505555 A JP2006505555 A JP 2006505555A JP 2004543826 A JP2004543826 A JP 2004543826A JP 2004543826 A JP2004543826 A JP 2004543826A JP 2006505555 A JP2006505555 A JP 2006505555A
Authority
JP
Japan
Prior art keywords
side chain
compound
treatment
alkyl
dogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505555A5 (enExample
Inventor
イアン・アレキサンダー・シールズ
デイビッド・フェアリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland
Original Assignee
University of Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland filed Critical University of Queensland
Publication of JP2006505555A publication Critical patent/JP2006505555A/ja
Publication of JP2006505555A5 publication Critical patent/JP2006505555A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2004543826A 2002-10-16 2003-10-16 骨関節症の治療 Pending JP2006505555A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952086A AU2002952086A0 (en) 2002-10-16 2002-10-16 Treatment of osteoarthritis
PCT/AU2003/001373 WO2004035079A1 (en) 2002-10-16 2003-10-16 Treatment of osteoarthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011170931A Division JP2011241224A (ja) 2002-10-16 2011-08-04 骨関節症の治療

Publications (2)

Publication Number Publication Date
JP2006505555A true JP2006505555A (ja) 2006-02-16
JP2006505555A5 JP2006505555A5 (enExample) 2006-11-24

Family

ID=28795579

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004543826A Pending JP2006505555A (ja) 2002-10-16 2003-10-16 骨関節症の治療
JP2011170931A Pending JP2011241224A (ja) 2002-10-16 2011-08-04 骨関節症の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011170931A Pending JP2011241224A (ja) 2002-10-16 2011-08-04 骨関節症の治療

Country Status (6)

Country Link
US (2) US7659246B2 (enExample)
EP (1) EP1575606A4 (enExample)
JP (2) JP2006505555A (enExample)
AU (2) AU2002952086A0 (enExample)
CA (1) CA2542513A1 (enExample)
WO (1) WO2004035079A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526299A (ja) * 2007-05-01 2010-07-29 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ類において骨関節炎を診断するための方法および組成物

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
ATE509632T1 (de) * 2002-10-16 2011-06-15 Promics Pty Ltd Behandlung von entzündlicher darmerkrankung
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
EP1498422A1 (de) 2003-07-17 2005-01-19 Jerini AG C5a-Rezeptor-Antagonisten
WO2009151634A1 (en) * 2008-06-12 2009-12-17 The Board Of Trustees Of The Leland Stanford Junior University Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
ES2929575T3 (es) 2011-06-06 2022-11-30 Novo Nordisk As Anticuerpos terapéuticos
DK2994488T3 (da) * 2013-05-08 2022-10-03 Novo Nordisk As Anvendelse af c5ar-antagonister
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders
CN114594780B (zh) * 2022-01-24 2024-11-12 国家康复辅具研究中心 主动型假脚控制方法和系统以及终端滑模控制器

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509506A (ja) * 1997-07-09 2001-07-24 アストラ・フアーマシユウテイカルズ・リミテツド 新規な化合物
JP2002501528A (ja) * 1997-05-28 2002-01-15 アストラゼネカ・アクチエボラーグ 新規な化合物
JP2002508767A (ja) * 1997-06-25 2002-03-19 ザ・ユニバーシティ・オブ・クイーンズランド Ｃ５ａ受容体およびＧタンパク質結合受容体の環状アゴニストおよびアンタゴニスト

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
US5643872A (en) * 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
US5707622A (en) * 1994-03-03 1998-01-13 Genentech, Inc. Methods for treating ulcerative colitis
US5614370A (en) * 1994-03-18 1997-03-25 Merck & Co., Inc. Assay to identify human C5a antagonists and agonists
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
AU3729295A (en) * 1994-09-23 1996-04-09 Alexion Pharmaceuticals, Inc. Methods for the treatment of inflammatory joint disease
US5935796A (en) * 1995-06-30 1999-08-10 The University Of Melbourne Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
US6013764A (en) * 1996-07-17 2000-01-11 Ortho Pharmaceutical Corp. Liquid phase peptide synthesis of KL-4 pulmonary surfactant
CA2292339A1 (en) * 1997-06-13 1998-12-17 Ludwig Institute For Cancer Research Smad6 and uses thereof
US5916898A (en) * 1997-10-24 1999-06-29 Zeneca Limited Phenanthroline derivatives
US7410995B1 (en) * 1998-08-14 2008-08-12 Gpi Nil Holdings Inc. N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
ATE509632T1 (de) * 2002-10-16 2011-06-15 Promics Pty Ltd Behandlung von entzündlicher darmerkrankung
AU2002952129A0 (en) * 2002-10-17 2002-10-31 The University Of Queensland Treatment of hypersensitivity conditions
AU2003902586A0 (en) * 2003-05-26 2003-06-12 The University Of Queensland Treatment of burns
AU2003902743A0 (en) * 2003-06-02 2003-06-19 Promics Pty Limited Process for the preparation of cyclic peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002501528A (ja) * 1997-05-28 2002-01-15 アストラゼネカ・アクチエボラーグ 新規な化合物
JP2002508767A (ja) * 1997-06-25 2002-03-19 ザ・ユニバーシティ・オブ・クイーンズランド Ｃ５ａ受容体およびＧタンパク質結合受容体の環状アゴニストおよびアンタゴニスト
JP2001509506A (ja) * 1997-07-09 2001-07-24 アストラ・フアーマシユウテイカルズ・リミテツド 新規な化合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526299A (ja) * 2007-05-01 2010-07-29 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ類において骨関節炎を診断するための方法および組成物
US8759258B2 (en) 2007-05-01 2014-06-24 Hill's Pet Nutrition, Inc. Methods and compositions for diagnosing osteoarthritis in a feline

Also Published As

Publication number Publication date
US7659246B2 (en) 2010-02-09
CA2542513A1 (en) 2004-04-29
EP1575606A1 (en) 2005-09-21
WO2004035079A1 (en) 2004-04-29
US20060234921A1 (en) 2006-10-19
AU2002952086A0 (en) 2002-11-07
US20100267639A1 (en) 2010-10-21
JP2011241224A (ja) 2011-12-01
AU2003269609B2 (en) 2008-11-20
AU2003269609A1 (en) 2004-05-04
EP1575606A4 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
JP2011241224A (ja) 骨関節症の治療
AU2011272137B2 (en) Novel peptide and use thereof
CA2695504C (en) Compositions and methods for treatment and prevention of osteoarthritis
JP2011241214A (ja) 線維症の処置におけるＣ５ａ受容体アンタゴニストの使用
JP2005515973A (ja) Ｇタンパク質結合受容体アンタゴニストとしての環状ペプチド
US20090004264A1 (en) Methods for treating and ameliorating the symptons of inflammatory bowel diseases
CA2983977C (en) Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders
JP2025170421A (ja) 全身性硬化症の予防または治療用薬学的組成物
JP2006528208A (ja) コンプリメント５ａ受容体阻害剤を使用する出血ショックの処置
JP2006505556A (ja) 過敏症の治療
AU2003215446B2 (en) Use of C5a receptor antagonist in the treatment of fibrosis
AU2003269602B2 (en) Treatment of inflammatory bowel disease
AU2003266862B2 (en) Treatment of hypersensitivity conditions
ES2366538T3 (es) Tratamiento de la enfermedad inflamatoria intestinal.
CN118236380A (zh) 盐酸布那唑嗪在防治肠缺血再灌注损伤中的应用
AU2003269602A1 (en) Treatment of inflammatory bowel disease
AU2003266862A1 (en) Treatment of hypersensitivity conditions
AU2004238089A1 (en) Treatment of haemorrhagic shock using complement 5a receptor inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060929

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100323

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100622

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20110127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110412